What is Evinacumab: Uses, Dosage, Side Effects and More

Evinacumab is a specialized injectable medication designed to lower extremely high cholesterol levels in people with a rare genetic condition called homozygous familial hypercholesterolemia (HoFH). This powerful treatment works differently from typical cholesterol medications by blocking a specific protein that prevents your body from removing bad cholesterol from your blood.

If you or someone you care about has been diagnosed with HoFH, you're likely feeling overwhelmed by the medical terms and treatment options. This medication represents a significant breakthrough for people whose cholesterol levels remain dangerously high despite trying other treatments.

What is Evinacumab?

Evinacumab is a monoclonal antibody medication that targets a protein called ANGPTL3 (angiopoietin-like protein 3). This protein normally interferes with your body's ability to break down fats and cholesterol in your bloodstream.

Think of ANGPTL3 as a brake that slows down your body's natural cholesterol-clearing system. Evinacumab releases that brake, allowing your body to process and remove cholesterol more effectively. This medication is specifically designed for people with homozygous familial hypercholesterolemia, a rare genetic condition affecting roughly 1 in 300,000 people worldwide.

The medication comes as a clear, colorless solution that's given through an intravenous (IV) infusion directly into your bloodstream. This delivery method ensures the medication reaches your system quickly and works at full strength.

What is Evinacumab Used For?

Evinacumab is specifically approved to treat homozygous familial hypercholesterolemia (HoFH) in adults and children 12 years and older. HoFH is a serious genetic condition where both parents pass on faulty genes that control cholesterol processing.

People with HoFH typically have LDL cholesterol levels that are 4-6 times higher than normal, often exceeding 400-500 mg/dL. These extremely high levels can lead to heart attacks, strokes, and other cardiovascular problems at a very young age, sometimes even in childhood or teenage years.

Your doctor will typically prescribe evinacumab when other cholesterol-lowering treatments haven't been effective enough. This includes situations where statins, PCSK9 inhibitors, and other medications haven't brought your cholesterol down to safer levels.

The medication is used alongside dietary changes and other lipid-lowering therapies as part of a comprehensive treatment plan. It's not meant to replace other treatments but rather to work together with them for maximum effectiveness.

How Does Evinacumab Work?

Evinacumab works by blocking ANGPTL3, a protein that normally prevents your body from breaking down triglycerides and cholesterol effectively. When this protein is blocked, your body can clear fats from your bloodstream much more efficiently.

This is a particularly strong medication in terms of cholesterol reduction. Clinical studies show it can lower LDL cholesterol by 47% on average, which is substantial for people who haven't responded well to other treatments.

Unlike statins that work in your liver to reduce cholesterol production, evinacumab works in your bloodstream to help remove cholesterol that's already circulating. This dual approach is why it's often used alongside other medications rather than replacing them entirely.

The medication's effects are long-lasting, with each infusion providing cholesterol-lowering benefits for about a month. This extended action means you won't need frequent dosing, which can make managing your treatment more convenient.

How Should I Take Evinacumab?

Evinacumab is given as an intravenous infusion every four weeks at a healthcare facility or infusion center. The standard dose is 15 mg per kilogram of your body weight, administered slowly over about 60 minutes.

You don't need to fast or avoid eating before your infusion. In fact, eating a light meal beforehand can help you feel more comfortable during the treatment. Staying well-hydrated by drinking plenty of water before and after your infusion is also helpful.

Your healthcare team will monitor you closely during each infusion and for at least 30 minutes afterward. They'll check your vital signs and watch for any immediate reactions. The infusion room is typically comfortable, and you can bring books, tablets, or other quiet activities to pass the time.

Before each infusion, your healthcare provider may give you medications to prevent allergic reactions. These might include antihistamines or corticosteroids, depending on your individual needs and medical history.

How Long Should I Take Evinacumab For?

Evinacumab is typically considered a long-term treatment for managing homozygous familial hypercholesterolemia. Since HoFH is a lifelong genetic condition, most people need ongoing treatment to keep their cholesterol levels controlled.

Your doctor will regularly monitor your cholesterol levels, usually every 3-6 months, to assess how well the medication is working. They'll also check for any side effects and adjust your overall treatment plan as needed.

The decision about continuing treatment depends on several factors: how well your cholesterol levels respond, whether you experience any significant side effects, and your overall health status. Some people may need to continue treatment indefinitely, while others might be able to reduce frequency or try alternative approaches over time.

Never stop taking evinacumab suddenly without discussing it with your doctor first. Your cholesterol levels could rise quickly, potentially putting you at increased risk for cardiovascular problems.

What Are the Side Effects of Evinacumab?

Most people tolerate evinacumab well, but like all medications, it can cause side effects. The most common reactions are generally mild and manageable with proper monitoring and care.

Here are the side effects you're most likely to experience, keeping in mind that many people have few or no problems with this medication:

• Infusion-related reactions like mild fever, chills, or feeling flushed during or shortly after treatment
• Upper respiratory tract infections such as cold-like symptoms or sinus congestion
• Fatigue or feeling more tired than usual for a day or two after infusion
• Headaches that are typically mild and respond well to over-the-counter pain relievers
• Nausea or mild stomach upset, especially on infusion days
• Dizziness or lightheadedness, particularly when standing up quickly

These common side effects usually improve on their own within a few days and become less noticeable as your body adjusts to the medication.

While less common, there are some more serious side effects that require immediate medical attention:

• Severe allergic reactions with symptoms like difficulty breathing, swelling of face or throat, or widespread rash
• Significant changes in liver function tests, which your doctor monitors through regular blood work
• Unusual bleeding or bruising that doesn't have an obvious cause
• Persistent high fever or signs of serious infection
• Severe or worsening fatigue that interferes with daily activities

Your healthcare team knows how to recognize and manage these reactions quickly. They'll always have emergency medications available during your infusions and will teach you what warning signs to watch for at home.

Who Should Not Take Evinacumab?

Evinacumab isn't suitable for everyone, and there are specific situations where your doctor will recommend against using this medication. The most important factor is having a confirmed diagnosis of homozygous familial hypercholesterolemia, as this medication is specifically designed for this rare condition.

You should not receive evinacumab if you've had a severe allergic reaction to this medication or any of its components in the past. Signs of such reactions include difficulty breathing, severe swelling, or widespread skin reactions that required emergency treatment.

Your doctor will carefully evaluate whether this medication is right for you if you have certain health conditions:

• Active liver disease or significantly elevated liver enzymes
• Severe kidney disease or are on dialysis
• Active infections or a compromised immune system
• Bleeding disorders or are taking blood-thinning medications
• Pregnancy or planning to become pregnant
• Breastfeeding or planning to breastfeed

Children under 12 years old should not receive evinacumab, as safety and effectiveness haven't been established in this age group. However, research is ongoing to determine if it might be safe and effective for younger children with HoFH.

If you're taking other medications, especially those that affect your immune system or liver function, your doctor will need to review all your medications carefully before starting evinacumab.

Evinacumab Brand Names

Evinacumab is marketed under the brand name Evkeeza in the United States and many other countries. This is currently the only brand name available for this medication.

The full generic name is evinacumab-dgnb, which helps distinguish it from other monoclonal antibodies that might be developed in the future. When you receive your medication, you'll see "Evkeeza" on the packaging and infusion bags.

Since this is a relatively new medication that was first approved in 2021, there are no generic versions available yet. The medication is manufactured by Regeneron Pharmaceuticals and is distributed through specialty pharmacies and infusion centers.

Evinacumab Alternatives

While evinacumab is specifically designed for homozygous familial hypercholesterolemia, there are other treatment options your doctor might consider depending on your specific situation and how well you respond to different therapies.

Traditional cholesterol-lowering medications that are often used alongside or instead of evinacumab include high-dose statins like atorvastatin or rosuvastatin. These work by reducing cholesterol production in your liver, though they're often not strong enough on their own for HoFH.

PCSK9 inhibitors such as evolocumab (Repatha) or alirocumab (Praluent) represent another class of injectable medications that can significantly lower cholesterol. These work differently from evinacumab and are sometimes used in combination with it.

For some people with HoFH, LDL apheresis might be an option. This is a procedure similar to dialysis where your blood is filtered to remove cholesterol directly. It's typically done every 1-2 weeks and can be very effective, though it's more time-consuming than medication.

Other medications that might be part of your treatment plan include ezetimibe (Zetia), which blocks cholesterol absorption in your intestines, and bile acid sequestrants like colesevelam (Welchol).

Is Evinacumab Better Than PCSK9 Inhibitors?

Evinacumab and PCSK9 inhibitors work through different mechanisms, so comparing them directly isn't straightforward. Both are powerful cholesterol-lowering medications, but they're often used in different situations or even together.

PCSK9 inhibitors are typically tried first because they've been available longer and have more extensive safety data. They're also approved for a broader range of cholesterol conditions, not just HoFH. These medications can lower LDL cholesterol by 50-60% in most people.

Evinacumab offers some unique advantages for people with HoFH. It works even when LDL receptors aren't functioning properly, which is often the case in HoFH. This makes it effective for people who don't respond well to PCSK9 inhibitors or statins.

The choice between these medications depends on your specific genetic type of HoFH, how you've responded to other treatments, and your individual health factors. Many people actually use both types of medications together for maximum cholesterol reduction.

Your doctor will consider factors like your current cholesterol levels, previous treatment responses, lifestyle factors, and personal preferences when deciding which approach is best for you.